Atara Biotherapeutics, Inc.
NASDAQ:ATRA
11.4 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -276.126 | -228.302 | -340.141 | -306.62 | -290.976 | -230.699 | -119.491 | -79.049 | -57.221 | -28.006 | -8.773 | -12.33 |
| Depreciation & Amortization
| 4.829 | 5.653 | 9.345 | 8.332 | 7.07 | 3.732 | 0.956 | 0.383 | 0.048 | 0.006 | 0.004 | 0 |
| Deferred Income Tax
| 0 | 0 | 1.79 | 0.958 | -0.303 | -1.885 | 0 | 0 | 0 | 0.526 | 0 | 0 |
| Stock Based Compensation
| 45.386 | 53.838 | 53.865 | 51.351 | 51.696 | 33.817 | 23.1 | 16.784 | 10.251 | 10.101 | 1.713 | 0.876 |
| Change In Working Capital
| 15.341 | -61.468 | 52.584 | 63.685 | -4.148 | 15.003 | 7.201 | -0.725 | 6.186 | -0.003 | 1.094 | 0 |
| Accounts Receivables
| 6.113 | -39.235 | 0.264 | -1.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -8.12 | -1.586 | 3.343 | -1.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -3.13 | -9.211 | 9.067 | -0.815 | 4.213 | -1.958 | 2.163 | 0.981 | 1.005 | -0.164 | 0.485 | 0 |
| Other Working Capital
| 20.478 | -11.436 | 39.91 | 67.002 | -8.361 | 16.961 | 5.038 | -1.706 | 5.181 | 0.161 | 0.609 | 0 |
| Other Non Cash Items
| 17.593 | -40.151 | 2.035 | 1.535 | 1.035 | 0.26 | 0.732 | 2.582 | 3.58 | 0.748 | -0.004 | 9.855 |
| Operating Cash Flow
| -192.977 | -270.43 | -220.522 | -180.759 | -235.626 | -179.772 | -87.502 | -60.025 | -37.156 | -16.628 | -5.966 | -2.475 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -1.223 | -4.193 | -10.58 | -4.513 | -5.733 | -35.925 | -20.232 | -3.02 | -0.29 | -0.046 | -0.003 | -0.027 |
| Acquisitions Net
| 0 | 94.765 | -32.838 | 116.215 | 0.161 | 0 | 0 | -83.741 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -83.648 | -180.589 | -301.129 | -425.868 | -270.23 | -466.489 | -176.459 | -304.928 | -379.776 | -95.525 | 0 | 0 |
| Sales Maturities Of Investments
| 208.712 | 292.973 | 333.967 | 309.653 | 336.261 | 306.125 | 296.6 | 391.689 | 160.133 | 12.208 | 0 | 0 |
| Other Investing Activites
| 0.025 | 207.149 | 32.838 | -116.215 | 66.192 | -160.364 | -1.2 | 83.741 | -0.194 | -83.317 | 0 | 0 |
| Investing Cash Flow
| 123.866 | 202.956 | 22.258 | -120.728 | 60.459 | -196.289 | 98.709 | 83.741 | -220.127 | -83.363 | -0.003 | -0.027 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.947 | -0.518 | -0.254 | -0.389 | -0.486 | -0.528 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 2.136 | 21.891 | 98.697 | 422.969 | 188.617 | 340.876 | 19.156 | 0 | 263.434 | 56.455 | 0 | 5.037 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.094 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.821 | 31.711 | 5.501 | 4.994 | 0.655 | 17.188 | 0.892 | 0.506 | -4.208 | 13.818 | 53.377 | 10.086 |
| Financing Cash Flow
| 2.01 | 53.084 | 103.944 | 427.574 | 188.786 | 357.536 | 20.048 | 0.506 | 259.226 | 70.273 | 53.377 | 15.123 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.094 | 0 | 0 | 0 |
| Net Change In Cash
| -67.101 | -14.39 | -94.32 | 126.087 | 13.619 | -18.525 | 31.255 | 24.222 | 1.849 | -29.718 | 47.408 | 12.621 |
| Cash At End Of Period
| 25.987 | 93.088 | 107.478 | 201.798 | 75.711 | 62.092 | 79.223 | 47.968 | 23.746 | 21.897 | 51.615 | 12.621 |